Clinical Trials Directory

Trials / Completed

CompletedNCT03374696

Theater in School Sex Education - a Randomized Controlled Study

Prevention of Chlamydia Infection With Theater in School Sex Education - a Randomized Controlled Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
826 (actual)
Sponsor
Örebro University, Sweden · Academic / Other
Sex
All
Age
13 Years – 15 Years
Healthy volunteers
Accepted

Summary

The study evaluated if interactive theater in school sex education affects student knowledge, attitudes and behavior regarding condom use. The intervention group got a play, value exercises, chlamydia games, condom school and interactive replay with professional actors and staff from a youth guidance center. The control group got standard sex education from school staff, based on the education guidelines of the Swedish National Agency for Education.

Detailed description

The spread of chlamydia indicates that current preventive work with condoms is insufficient. Research shows that reasons behind increased chlamydia include youths taking more sexual risks, due to altered attitudes and sexual behaviors. Since only condoms protect against both sexually transmitted infections (STIs) and unwanted pregnancy, the goal of the World Health Organization (WHO) chlamydia prevention program is to increase condom use. Research suggests that school is the most important arena for sex education, reaching all youths early in life, when many values on sex and relationships are instilled. International studies on theater in sex education indicate effects like increased knowledge on the topic, and partially changed attitudes and behaviors among youths. Furthermore, several studies show that youths feel theater is a good method for sex education and a supplement to standard education.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSAFETY
BEHAVIORALStandard education

Timeline

Start date
2016-12-01
Primary completion
2017-03-31
Completion
2017-03-31
First posted
2017-12-15
Last updated
2017-12-15

Source: ClinicalTrials.gov record NCT03374696. Inclusion in this directory is not an endorsement.